Ulrich Ettelt

Ulrich Ettelt is a Scientist currently employed at Corden Pharma since October 2024, previously holding similar roles at ProtaGene from April 2022 to October 2024, where responsibilities included validation of analytical methods and quality control for protein-based therapeutics. Prior experience includes a position as a Research Associate at Octapharma focusing on biological assay development and a Master Thesis Student role at the Leibniz Institute for Natural Product Research and Infection Biology, where activities encompassed protein engineering and data processing with R programming. Ulrich also completed a Bachelor Thesis at the Institute of Physiological Chemistry at University Hospital Essen, investigating cell damage mechanisms. Ulrich holds a Master's degree in Pharmaceutical Biotechnology from Fachhochschule Jena and a Bachelor's degree in Pharmaceutical Chemistry from Cologne University of Applied Sciences.